Associations of wearable tracker use with physical activity and health outcomes in patients with cancer: Findings from the HINTS-SEER (2021).

Authors

null

Junlan Pu

38 Xueyuan Rd, Haidian District, Beijing, China

Junlan Pu , Youmin Cho

Organizations

38 Xueyuan Rd, Haidian District, Beijing, China, University of Texas Health Science Center at Houston, Houston, TX

Research Funding

No funding received
None.

Background: Physical inactivity is a global issue for cancer survivors. Wearable trackers are promising to address physical inactivity by providing real-time feedback on physical activity (PA) and offer opportunities for self-monitoring and goal setting. Meta-analysis has reported the effects of interventions that incorporate wearable trackers on improved physical inactivity and related health outcomes (e.g., BMI, anxiety and depression, and self-rated health). However, wearable trackers were often used an an adjunct to PA interventions, and the effectiveness of wearable trackers alone is unknown. The aim of this study was to determine the association of wearable trackers with PA and health outcomes (BMI, anxiety and depression, and self-rated health) in patients with cancer, using a national dataset. Methods: Data from 957 cancer survivors from Health Information National Trends Survey – Surveillance, Epidemiology, and End Results Program (HINTS-SEER-2021) were analyzed. The outcome variables examined were: time spent in moderate to vigorous physical activity (MVPA), weekly frequency of strength training, BMI, anxiety/depression levels, and self-assessed health status. The primary independent variable was whether cancer survivors had used wearable devices within the past 12 months. Design-based linear regression for continuous outcome variables and ordinal logistic regression for ordinal outcome variables were conducted to determine the associations, after controlling for sociodemographic, cancer-related clinical (i.e., type, stage, time since diagnosis), and general health-related factors (i.e., BMI and smoking). All data analyses accounted for the complex survey design and sample weights. Results: Only 28% of cancer survivors reported wearable devices use. Bivariate analyses showed younger age, higher income, and employed status were significantly associated with wearable tracker use (P<.001). Wearable devices use was significantly associated with higher time spent in MVPA (b=37.94, 95% OR:8.38, 67.5; P=.01), more frequent strength training per week (adjusted OR=1.50, 95% OR: 1.09, 2.06; P=.01), and better self-rated health status (adjusted OR=1.58, 95% OR:1.09, 2.29; P=.01), but not associated with BMI or anxiety/depression. Conclusions: This study suggests that the uptake of wearable devices is low and highlights the digital divide among patients with cancer. This study has confirmed the associations of wearable tracker use with PA and self-rated health, supporting using wearable trackers as a promising tool to facilitate PA promotion.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Breakthrough

Session Type

Poster Session

Session Title

Poster Session B

Track

Gastrointestinal Cancer,Gynecologic Cancer,Head and Neck Cancer,Quality of Care,Genetics/Genomics/Multiomics,Healthcare Equity and Access to Care,Healthtech Innovations,Models of Care and Care Delivery,Population Health,Viral-Mediated Malignancies

Sub Track

Other Technology and Innovations

Citation

JCO Global Oncology 9, 2023 (suppl 1; abstr 131)

DOI

10.1200/GO.2023.9.Supplement_1.131

Abstract #

131

Poster Bd #

H7

Abstract Disclosures

Similar Abstracts

First Author: D'Ambra Dent

Abstract

2023 ASCO Genitourinary Cancers Symposium

Contemporary use of wearable activity monitors in prostate cancer survivors: A scoping review.

First Author: Brandon Noorvash

First Author: Charles Stewart Kamen

Abstract

2024 ASCO Annual Meeting

Personalized risk assessment of new onset depression in long-term cancer survivors.

First Author: Melissa Taylor